Discover 2,413 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,413
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
for
Large B-cell Lymphoma
Location: Bethesda MD, Washington D.C. DC, Fairfax VA,
Sponsor: Allogene Therapeutics
Sex: All
Age: 18+
Code: NCT06500273
Phase2, Recruiting
Change in MAPSE During Treatment of Sepsis
for
Sepsis
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18+
Code: NCT05634733
Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma
Location: Bethesda MD, Fort Belvoir VA, Baltimore MD, Newark DE,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05552222
Phase3, Recruiting
Induction of Labor in Morbidly Obese Patients
for
Morbid Obesity, Pregnancy
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: Female
Age: 18+
Code: NCT06199154
Early_phase1, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
GEMINI-NSCLC: NSCLC Biomarker Study
for
Non-Small Cell Lung Cancer
Location: Bethesda MD, Baltimore MD, Frederick MD, York PA,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05236114
Recruiting
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
for
Advanced Melanoma
Location: Bethesda MD, Pittsburgh PA, Canton OH, Toronto,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT06697301
Phase2, Phase3, Recruiting
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Bethesda MD, Washington D.C. DC, Baltimore MD,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06479135
Phase3, Recruiting
Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)
for
Acute Leukemia, Acute Lymphoblastic Lymphoma
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 0+
Code: NCT06803745
Recruiting
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Bethesda MD, Charlottesville VA, Albany NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05947851
Phase3, Recruiting
Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC